| |
|
|
|
Aptevo Therapeutics Inc.  
|
|
0.69 0.021 (0.03%) |
09-20 16:00 |
|
Open: |
0.67 |
Pre close: |
0.666 |
Target:
|
0.90
|
|
High: |
0.69 |
Low: |
0.6605 |
Resistance:
|
0.77
0.86
|
|
Volume: |
432,322 |
Market Cap: |
31M |
Support:
|
0.63
0.53
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.67
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
0.68  |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
0.80 |
Stochastic Oscillator |
%K(14,3):
|
51.29 |
|
MA(250): |
1.59 |
%D(3): |
38.20 |
|
Average Volume(K) |
3-Month: |
54048
|
52-Week |
High:
|
5.21 |
|
10-Days: |
34324 |
Low: |
0.49 |
|
RSI |
RSI(14):
|
43.71 |
Change(%): |
-86.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.762 |
Return on Equity (ttm) |
-126.6 |
Shares Out. (M) |
45.10 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
-40.1 |
Shares Float (M) |
31.18 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.31 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
7.8 |
% Held by Institutions |
41.88 |
|
Forward EPS |
-1.321 |
Gross Profit (p.s.) |
-0.522 |
Shares Short (K) |
247 |
|
Book Value (p.s.) |
0.580 |
EBITDA (p.s.) |
-1.058 |
P/E |
-0.39 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.19 |
|
Profit Margin |
-195.99 |
Operating Cash Flow
(M) |
-48.17 |
P/S |
34576664.00 |
|
Operating Margin |
-188.52 |
Levered Free Cash Flow
(M) |
-27.12 |
P/CF |
-0.65 |
|
|
|
|
|
|
